运动与Toll样受体的研究

研究了Toll样受体(TLRs)与免疫的基本关系,运动与营养对TLRs表达的影响。指出TLRs与人体的各种功能系统关系密切,通过长期运动与适当的营养手段可以良性降低TLRs的表达,进而提高运动员以及健身群众的身体免疫机能。     

去泛素化酶7与髓样分化因子88蛋白相互作用的研究

Toll-like受体（TLRs）介导的信号途径不仅参与机体识别病原微生物入侵、诱导免疫应答,而且还可诱导机体产生破坏性炎症反应．通过免疫共沉淀、免疫荧光共定位、间接免疫荧光等实验方法鉴定去泛素化酶7（USP7）和TLR信号途径中重要接头蛋白——髓样分化因子88（MyD88）的相互作用,结果表明USP7和MyD88可在细胞质中共定位并可发生相互作用．该研究对阐释TLR信号通路的机制奠定了重要的基础．     

Toll样受体2的研究进展

Toll样受体家族（TOU likereceptors,TLRs）是先天性免疫系统进化过程中形成的非常保守的模式识别受体家族,Toll样受体2（T011-likereceptors2,TLR2）是已经克隆的Toll样受体家族中表达范围最广,识别病原微生物种类最多的成员。它可单独或协同其他Toll样受体家族成员完成对病原体相关分子模式的识别,触发机体对致病微生物的级联免疫应答,尤其是针对细胞毒素的抗炎症反应具有重要的作用,已经成为多种疾病治疗的新靶点。文章对N-SL动物TLR2的分布,结构特征,配体识别,信号转导及其生物学功能的最新研究进展进行了综述。     

黄芩提取物及含药血清体外抑制呼吸道合胞病毒作用的实验研究

研究了黄芩提取物及其含药血清体外抑制呼吸道合胞病毒（RSV）的作用。通过细胞培养,采用观察细胞病变（CPE）和活细胞染色计数法（MTT）,观察清热抗感冲剂及其含药血清在Hep-2细胞中抑制RSV的作用。结果表明：黄芩提取物及其含药血清具有不同程度抑制RSV病毒复制作用,其半数中毒浓度（TC50）分别为3924mg/L、1/4.35稀释度;半数有效浓度（IC50）为165mg/L、1/54稀释度;治疗指数分别为23.78、10.83。这表明黄芩提取物及其含药血清具有抑制RSV在Hep-2细胞内复制的作用。     

实时荧光反转录PCR检测呼吸道合胞病毒

目的 建立快速、准确、特异的实时荧光反转录PCR方法检测呼吸道合胞病毒(RSV).方法 根据RSV基因序列设计引物和探针并优化实时荧光反转录PCR反应体系,对686例临床标本进行检测,阳性结果测序验证.结果 本实验所建立实时荧光反转录PCR方法可准确、特异地检测RSV;686名呼吸道感染患儿中RSV感染达到16.5%(113/686).结论 本研究建立的RSV实时荧光反转录PCR方法快速、准确,结果可靠,可用于儿童RSV感染的临床诊断.     

靶向树突状细胞的呼吸道合胞病毒F重组蛋白的构建与体外活性分析

分析以人呼吸道合胞病毒(Human respiratory syncytial virus,RSV)融合糖蛋白(fusion glycoprotein,F)为抗原靶向DEC205/CD205受体策略对重组F蛋白表达及活性的影响.F蛋白是RSV的重要中和抗原,克隆RSV F蛋白胞外区的编码基因至可识别鼠树突状细胞(Dendritic cells,DCs)DEC205受体的单链抗体(single chain antibody of anti-DEC205,scDEC)的C端,构建可表达重组F蛋白(scDECF)的质粒pVAX1/scDECF,Western blot方法检测scDECF的表达,免疫荧光法和流式细胞术检测表达的scDECF与DEC205受体的结合活性.经Western blot证实在pVAX1/scDECF转染的293T细胞成功表达了scDECF.将所获得的细胞培养上清与表达鼠DEC205受体的细胞CHOmDEC205孵育,用免疫荧光和流式细胞术证实:与作为对照的重组F蛋白scISOF相比,所获得的scDECF与CHOmDEC205细胞呈现明显的结合.本研究成功表达了重组蛋白scDECF,且所获得的重组蛋白scDECF具有与表达DEC205受体的细胞特异性结合的活性.     

促生长激素样免疫活性细胞和生长抑素受体在文昌鱼（Branchiostoma belcheri）神经系统和哈氏窝的分布

用免疫组织化学与双标记染色技术对文昌鱼神经系统和哈氏窝进行生长激素（GH）和生长抑素受体（SSTR）免疫组织化学定位.研究结果显示，神经系统和哈氏窝均存在生长激素样免疫活性神经细胞和内分泌细胞及生长抑素3种亚型受体，且脑泡GH样免疫活性神经细胞和哈氏窝GH样细胞均与3种亚型生长抑素受体共存.这些结果证明了文昌鱼可能建立类似脊椎动物原始的抑制哈氏窝分泌生长激素的调控系统，为哈氏窝内分泌学及其进化提供了新的证据.     

NK细胞免疫识别及其调节机制与免疫相关性疾病

自然杀伤受体(NKR)和Toll样受体(TLR)是天然免疫系统最重要的二群天然免疫识别受体家族,位于机体抵抗外来侵袭的第一道防线.二者各自具有独特的识别外来或内源性的危险信号、区分自我和非我的识别机制,是启动固有免疫和适应性免疫应答的关键链接分子.NK细胞是天然免疫系统的核心成员,具有早期识别和清除病毒感染和肿瘤细胞等功能,同时也是连接天然免疫和获得性免疫的桥梁.以NK细胞为载体将TLRs/NKRs连接起来,可以较好地反映机体内外环境变化或刺激时固有免疫对适应性免疫的调节作用,为有效控制感染、炎症、肿瘤及自身免疫性疾病提供崭新的治疗策略.     

TLRs信号转导通路及负调控分子研究进展

生物机体存在着多种TLRs的负调控机制,以维持免疫反应的平衡.该文综述了Toll样受体(Toll-like receptors,TLRs)的结构、分布及主要的内源性和外源性配体,重点阐述TLRs信号通路的类型和转导机制,并分析论述TLRs信号通路中的负性调控分子.     

Role of toll-like receptors in regulatory functions of T and B cells

Pathogens can find their ways to most sites in the host. Pathogen sensors, such as Toll-like receptors （TLRs）, must be equally and broadly distributed on immune cells to combat them through innate and adaptive immunity. Most classes of TLRs are found in innate immune cells to obtain an immediate response against pathogens, but recent studies indicate that a number of TLRs are wildly expressed in T and B cells, suggesting TLRs also directly regulate adaptive immune responses. Due to the rapid increase of new information on the multiple roles of TLRs, in this paper we aim to review several main properties of TLRs and their direct role in T and B cells. This review consists of 6 parts： （i） Characteristics of Toll-like receptors （TLRs） and signaling; （ii） signalling pathways of TLRs; （iii） TLR expressions on human leukocytes; （iv） TLR expressions and functions in the Thl, CD4^＋CD45RO^＋ memory T cells and regulatory/suppressor T as well as B cell populations; （v） therapeutic potential of TLR agonists; （Vi） discussion and perspective. The latest findings and potential therapeutic applications are discussed. There is growing evidence supporting the concept that TLR activation contributes not only to innate immunity but also to adaptive immunity, including direct regulation of both T and B lymphocytes by TLRs.     

Toll-like receptors in the induction of the innate immune response

The innate immune response is the first line of defence against infectious disease. The principal challenge for the host is to detect the pathogen and mount a rapid defensive response. A group of proteins that comprise the Toll or Toll-like family of receptors perform this role in vertebrate and invertebrate organisms. This reflects a remarkable conservation of function and it is therefore not surprising that studies of the mechanism by which they act has revealed new and important insights into host defence.     

The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.

Macrophages orchestrate innate immunity by phagocytosing pathogens and coordinating inflammatory responses. Effective defence requires the host to discriminate between different pathogens. The specificity of innate immune recognition in Drosophila is mediated by the Toll family of receptors; Toll mediates anti-fungal responses, whereas 18-wheeler mediates anti-bacterial defence. A large number of Toll homologues have been identified in mammals, and Toll-like receptor 4 is critical in responses to Gram-negative bacteria. Here we show that Toll-like receptor 2 is recruited specifically to macrophage phagosomes containing yeast, and that a point mutation in the receptor abrogates inflammatory responses to yeast and Gram-positive bacteria, but not to Gram-negative bacteria. Thus, during the phagocytosis of pathogens, two classes of innate immune receptors cooperate to mediate host defence: phagocytic receptors, such as the mannose receptor, signal particle internalization, and the Toll-like receptors sample the contents of the vacuole and trigger an inflammatory response appropriate to defence against the specific organism.     

A pathway profile-based method for drug repositioning

Finding new applications for existing pharmaceuticals,known as drug repositioning,is a validated strategy for resolving the problem of high expenditure but low productivity in drug discovery.Currently,the prevalent computational methods for drug repositioning are focused mainly on the similarity or relevance between known drugs based on their "features",including chemical structure,side effects,gene expression profile,and/or chemical-protein interactome.However,such drug-oriented methods may constrain the newly predicted functions to the pharmacological functional space of the existing drugs.Clinically,many drugs have been found to bind "off-target"(i.e.to receptors other than their primary targets),which can lead to undesirable effects.In this study,which integrates known drug target information,we propose a disease-oriented strategy for evaluating the relationship between drugs and disease based on their pathway profile.The basic hypothesis of this method is that drugs exerting a therapeutic effect may not only directly target the disease-related proteins but also modulate the pathways involved in the pathological process.Upon testing eight of the global best-selling drugs in 2010(each with more than three targets),the FDA(Food and Drug Administration,USA)-approved therapeutic function of each was included in the top 10 predicted indications.On average,60% of predicted results made using our method are proved by literature.This approach could be used to complement existing methods and may provide a new perspective in drug repositioning and side effect evaluation.     

Structural basis for signal transduction by the Toll/interleukin-1 receptor domains

Toll-like receptors (TLRs) and the interleukin-1 receptor superfamily (IL-1Rs) are integral to both innate and adaptive immunity for host defence. These receptors share a conserved cytoplasmic domain, known as the TIR domain. A single-point mutation in the TIR domain of murine TLR4 (Pro712His, the Lps(d) mutation) abolishes the host immune response to lipopolysaccharide (LPS), and mutation of the equivalent residue in TLR2, Pro681His, disrupts signal transduction in response to stimulation by yeast and gram-positive bacteria. Here we report the crystal structures of the TIR domains of human TLR1 and TLR2 and of the Pro681His mutant of TLR2. The structures have a large conserved surface patch that also contains the site of the Lps(d) mutation. Mutagenesis and functional studies confirm that residues in this surface patch are crucial for receptor signalling. The Lps(d) mutation does not disturb the structure of the TIR domain itself. Instead, structural and functional studies indicate that the conserved surface patch may mediate interactions with the down-stream MyD88 adapter molecule, and that the Lps(d) mutation may abolish receptor signalling by disrupting this recruitment.     

Intracellular pattern recognition receptors in the host response

The innate immune system relies on its capacity to rapidly detect invading pathogenic microbes as foreign and eliminate them. Indeed, Toll-like receptors are a class of membrane receptors that sense extracellular microbes and trigger anti-pathogen signalling cascades. Recently, intracellular microbial sensors have also been identified, including NOD-like receptors and the helicase-domain-containing antiviral proteins RIG-I and MDA5. Some of these cytoplasmic molecules sense microbial, as well as non-microbial, danger signals, but the mechanisms of recognition used by these sensors remain poorly understood. Nonetheless, it is apparent that these proteins are likely to have critical roles in health and disease.     

Localization of D-2 dopamine receptors to intrinsic striatal neurones by quantitative autoradiography

Recent work with positron emission and single photon emission computed tomography has demonstrated the feasibility of studying striatal dopamine receptors in the living human brain. For the proper interpretation of these studies in normal and diseased states, the cellular localization of these receptors must be definitively established. It has been claimed, on the basis of receptor binding studies with tissue homogenates in rats, that 30-50% of striatal D-2 dopamine receptors are located on axons or terminals of the corticostriatal pathway. This finding has been incorporated into major reviews and classifications of dopamine receptors. The recent development of quantitative autoradiographic methods for diffusible ligands has facilitated the study of neurotransmitter receptors in cytoarchitechtonically intact tissue. Because this technique provides the necessary anatomic resolution that is lacking in homogenate binding studies, we have used it to re-examine the localization of striatal dopamine receptors. Here we present evidence that D-2 receptors are located exclusively on kainic acid-sensitive intrinsic neuronal elements in the striatum. We report that discrete cortical ablation does not alter 3H-spiperone binding to rat striatum and thus our results do not support the existence of D-2 dopamine receptors on the terminals of the corticostriatal pathway.     

Critical role of Toll-like receptor signaling in NK cell activation

Toll-like receptors (TLRs) and NK cell receptors are the most important receptor superfamilies in innate immunity. TLRs act as the sensor of external pathogens, while NK cells detect alterations in endogenous protein expression on target cells through activating and inhibitory receptors. Accumulating data has demonstrated that TLRs and NK cell receptors can coordinate and regulate each other during immune responses, which contributes to the initiation of innate response and the priming of adaptive responses. TLRs can activate NK cell function directly or with the help of accessory cells in a cytokine or cell-to-cell contact dependent manner. More understanding of the recognition of innate receptors and interactions between them may provide important insights into the design of effective strategies to combat tumor and microbial infections. In this review, we summarize how TLRs and NK cells discriminate the self or non-self components respectively. And importantly, we pay more attention to the role of TLR sig-naling in induction of NK cell activation, responses and the crosstalk between them.     

Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide

Plasmacytoid dendritic cells (pDCs) sense viral and microbial DNA through endosomal Toll-like receptors to produce type 1 interferons. pDCs do not normally respond to self-DNA, but this restriction seems to break down in human autoimmune disease by an as yet poorly understood mechanism. Here we identify the antimicrobial peptide LL37 (also known as CAMP) as the key factor that mediates pDC activation in psoriasis, a common autoimmune disease of the skin. LL37 converts inert self-DNA into a potent trigger of interferon production by binding the DNA to form aggregated and condensed structures that are delivered to and retained within early endocytic compartments in pDCs to trigger Toll-like receptor 9. Thus, our data uncover a fundamental role of an endogenous antimicrobial peptide in breaking innate tolerance to self-DNA and suggest that this pathway may drive autoimmunity in psoriasis.